Publication | Open Access
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
58
Citations
25
References
2021
Year
No new or unexpected safety signals were observed from combining evofosfamide and ipilimumab, and evidence of therapeutic activity was noted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1